if prr can grow legs ; vla can fly!!

PRR's (Prima Biomed Ltd) price has gone up to 12 fold in the last month or two. The basis of this enthusiasm is due to access to significant funding and the beginning of the final stages of clinical trials and FDA approval of their Ovarian Cancer Vaccine. The excitement is linked to the progress of an American Company, Dendreon Corporation (listed on the NASDAQ as DNDN) which has completed its final clinical trials for a Prostate Cancer Vaccine, which is said to be based on similar technology as PRR's Ovarian Cancer Vaccine. Both products, I understand, are for final stage treatment of these specific cancers.
In essence VLA's (Viralytics Limited)products are based on, in my opinion, a uniquely specific and superior mode of action. Their cancer killing viral products will target an impressive list of cancers , including Malignant Melanoma, Breast Cancer, Prostate Cancer and Head and Neck Cancers.
They are presently proceeding to their next stage of clinical trials.